tiprankstipranks
Kintara Therapeutics (KTRA)
NASDAQ:KTRA

Kintara Therapeutics (KTRA) Stock Forecast & Price Target

677 Followers
See the Price Targets and Ratings of:

KTRA Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Kintara
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

KTRA Stock 12 Month Forecast

There Are No Analyst Ratings for KTRA In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

KTRA Financial Forecast

KTRA Earnings Forecast

Next quarter’s earnings estimate for KTRA is -$0.25 with a range of -$0.25 to -$0.25. The previous quarter’s EPS was -$0.24. KTRA beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.52% of the time in the same period. In the last calendar year KTRA has Underperformed its overall industry.
Next quarter’s earnings estimate for KTRA is -$0.25 with a range of -$0.25 to -$0.25. The previous quarter’s EPS was -$0.24. KTRA beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.52% of the time in the same period. In the last calendar year KTRA has Underperformed its overall industry.
No data currently available

KTRA Sales Forecast

The previous quarter’s earnings for KTRA were $0.00.
The previous quarter’s earnings for KTRA were $0.00.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group
Hold
Downgraded
10/31/23
Kintara Therapeutics Shares Plumb New Depths on VAL-083 FailureIn a research note, analyst Jason McCarthy said VAL-083 was the key driver of Maxims Kintara thesis, and that the drug was now removed from Maxims model.

KTRA Analyst Recommendation Trends

Rating
Sep 22
Nov 22
Feb 23
Jul 23
Oct 23
Strong Buy
2
1
0
1
1
Buy
0
0
0
0
0
Hold
2
4
5
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
5
5
4
3
In the current month, KTRA has received 1 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. KTRA average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

KTRA Stock Forecast FAQ

What is KTRA’s average 12-month price target, according to analysts?
Currently, no data Available
What is KTRA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for KTRA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is KTRA a Buy, Sell or Hold?
      Currently, no data Available
      What is Kintara Therapeutics’s price target?
      Currently, no data Available
      What do analysts say about Kintara Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of KTRA?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis